Cancer Imaging
Lung and Breast Carcinomas
Inbunden, Engelska, 2007
Av M. A. Hayat, M A Hayat
2 939 kr
- Concentrates on the application of imaging technology to the diagnosis and prognosis of lung and breast carcinomas, the two major worldwide malignancies
- Addresses the relationship between radiation dose and image quality
- Discusses the role of molecular imaging in identifying changes for the emergence and progression of cancer at the cellular and/or molecular levels
Produktinformation
- Utgivningsdatum2007-10-25
- Mått216 x 276 x 37 mm
- Vikt2 170 g
- FormatInbunden
- SpråkEngelska
- Antal sidor656
- FörlagElsevier Science
- ISBN9780123704689
Tillhör följande kategorier
Dr. Hayat has published extensively in the fields of microscopy, cytology, immunohistochemistry, immunocytochemistry, and antigen retrieval methods. He is Distinguished Professor, Department of Biological Sciences, Kean University, Union, New Jersey, USA.
- INSTRUMENTATION AND GENERAL APPLICATIONS CHAPTER 1. INTRODUCTIONCHAPTER 2. MULTIDETECTOR-ROW COMPUTED TOMOGRAPHY SCANNING: PROJECTED RISKS CHAPTER 3. POSITRON EMISSION TOMOGRAPHY SCANNING AND FUNCTIONAL ANATOMIC IMAGE FUSION CHAPTER 4. SINGLE - PHOTON EMISSION COMPUTED TOMOGRAPHY CHAPTER 5. DYNAMIC INFRARED IMAGING CHAPTER 6. IN VIVO BROADBAND SPECTROSCOPY CHAPTER 7. MAGNETIC RESONANCE SPECTROSCOPIC IMAGING CHAPTER 8. COMBINED Tl-WEIGHTED DYNAMIC CONSTANT AGENT-ENHANCED MAGNETIC RESONANCE IMAGING, HYDROGEN 1 MAGNETIC RESONANCE SPECTROSCOPY, AND PERFUSION MAGNETIC RESONANCE IMAGING CHAPTER 9. ULTRASOUND IMAGING CHAPTER 10. ROLE OF ULTRASOUND IN MOLECULAR IMAGING CHAPTER 11. WHOLE - BODY COMPUTED TOMOGRAPHY SCREENING CHAPTER 12. POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY WHOLE - BODY IMAGING CHAPTER 13. RADIATION DOSE IN COMPUTED TOMOGRAPHY CHAPTER 14. RISK OF CANCER FROM DIAGNOSTIC X-RAYSCHAPTER 15. LEGAL AND ETHICAL ISSUES IN RADIOLOGIC SCREENING CHAPTER 16. NEAR-INFRARED OPTICAL IMAGING OF PROTEASES IN CANCER CANCERS CHAPTER 17. ANTI-HER-2 ANTIBODY AS AN ANTITUMOR AGENT CHAPTER 18. IMAGING TO DETECT RECURRENT CANCER CHAPTER 19. ANTIBODY IMAGING AND THERAPY OF CANCER CHAPTER 20. MOVEMENT OF INVASIVE TUMOR CELLS: INTRAVITAL IMAGING CHAPTER 21. METASTASES: WHOLE - BODY MAGNETIC RESONANCE IMAGING CHAPTER 22. SOLID TUMORS: FUSED POSITRON EMISSION TOMOGRAPHY ICOMPUTED TOMOGRAPHY CHAPTER 23. INTRAOPERATIVE MAGNETIC RESONANCE IMAGING CHAPTER 24. PELVIC IMAGING: SINGLE - PROTON EMISSION COMPUTED TOMOGRAPHY CHAPTER 25. IMAGING TECHNOLOGY IN ANTICANCER EFFICACY EVALUATIONS CHAPTER 26. IMAGE-GUIDED CANCER THERAPY USING POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY CHAPTER 27. ONCOLOGICAL MOLECULAR IMAGINGCHAPTER 28. DIAGNOSTIC IMAGING OF CANCER: RADIOPHARMACEUTICALS CHAPTER 29. ADRENAL TUMORS: CURRENT VIEWS ON IMAGINGANGIOGRAPHY CHAPTER 30. COMPUTED TOMOGRAPH ANGIOGRAPHY CHAPTER 31. MAGNETIC RESONANCE ANGIOGRAPHY WITH PARALLEL IMAGING BREAST CANCER CHAPTER 32. DYNAMIC BREAST MAGNETIC RESONANCE IMAGING CHAPTER 33. SINGLE-PROTON EMISSION COMPUTED TOMOGRAPHY FOR EVALUATING AXILLARY LYMPH NODE STATUS IN BREAST CANCER PATIENTSCHAPTER 34. POSITRON EMISSION TOMOGRAPHY OF PATIENTS WITH A LOCOREGIONALL Y RECURRENCE OF BREAST CANCER CHAPTER 35. MAGNETIC RESONANCE IMAGING OF INVASIVE LOBULAR CARCINOMACHAPTER 36. IMAGING OF MICROCIRCULATION AND MICROVASCULATURE IN BREAST CANCER: DYNAMIC MAGNETIC RESONANCE CHAPTER 37. MAMMOGRAMS: COMPUTER-AIDED DETECTION WITH DOUBLE READING CHAPTER 38. DETECTION OF DISTANT RECURRENCE OF BREAST CANCER BY MAMMOGRAPHY SCREENINGCHAPTER 39. BREAST ULTRASOUND EXAMINATION CHAPTER 40. AXILLARY LYMPH NODE STATUS: SINGLE - PHOTON EMISSION COMPUTED TOMOGRAPHYCHAPTER 41: DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE I IMAGINGLUNG CANCER CHAPTER 42. POSITRON EMISSION TOMOGRAPHY AND FUNCTIONAL ANATOMIC FUSION IMAGING IN LUNG AND BREAST CANCERSCHAPTER 43. DIFFERENTIATED THYROID CARCINOMA LUNG METASTASES: RADIOIODINE THERAPY IMAGINGCHAPTER 44. NONS MALL CELL LUNG CARCINOMA: STEREOTACTIC IRRADIATION-COMPUTED TOMOGRAPHYCHAPTER 45. NONSMALL CELL LUNG CARCINOMA: 18F_ FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY CHAPTER 46. COMPUTED TOMOGRAPHY CHAPTER 47. TREATMENT OF NON-SMALL-CELL LUNG CANCER CHAPTER 48. LUNG METASTASES OF THYROID CANCER: WHOLE - BODY SCINTIGRAM CHAPTER 49. RETINOBLASTOMA: COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING CHAPTER 50. RENAL CANCER: MAGNETIC RESONANCE IMAGINGCHAPTER 51. LUNG TUMORS: 3 DEOXY-3-[18F] FLUOROTHYMIDINE-POSITRON EMISSION TOMOGRAPHYLIVER CANCER CHAPTER 52. HARMONIC IMAGING OF FOCAL LIVER LESIONS CHAPTER 53. IMAGING OF THE LIVER BY HELICAL COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCECHAPTER 54. HEPATOCELLULAR CANCER: MAGNETIC RESONANCE IMAGINGCHAPTER 55. HEPATOCELLULAR CARCINOMA AND ADENOMATOUS HYPERPLASIA: DYNAMIC COMPUTED TOMOGRAPHY AND A COMBINATION OF COMPUTED TOMOGRAPHY AND ANGIOGRAPHY CHAPTER 56. DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: MULTIDETECTOR ROW COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING CHAPTER 57. RADIOLOGICAL IMAGING OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTSCHAPTER 58. AFFERENT AND EFFERENT VESSELS OF PREMALIGNANT AND OVERT HEPATOCELLULAR CARCINOMA: COLOR DOPLER IMAGINGCHAPTER 59. CONTRAST-ENHANCED SONOGRAPHY FOR HEPATOCELLULAR CARCINOMA CHAPTER 60. INTRATUMORAL VASCULARITY IN SMALL HEP ATOCELLULAR CARCINOMA: CODED PHASE INVERSION HARMONICSCHAPTER 61. HEPATOCELLULAR CARCINOMA WITH NODULE-IN-NODULE APPEARANCE: CONTRAST-ENHANCED CODED PHASE INVERSION HARMONIC IMAGINGCHAPTER 62. IMAGING OF DYSPLASTIC NODULES AND SMALL HEP ATOCELLULAR CARCINOMASCHAPTER 63. AFFERENT AND EFFERENT VESSELS OF PREMALIGNANT AND OVERT HEPATOCELLULAR CARCINOMA: COLOR DOPLER IMAGINGCHAPTER 64. ASSESSMENT OF HEPATOCELLULAR CARCINOMA: CONTRAST -ENHANCED PERFUSIONAL SONOGRAPHYCHAPTER 65. DEPICTION OF HEPATOCELLULAR CARCINOMA: DYNAMIC STEADY STATE FREE PRECESSION MAGNETIC RESONANCE IMAGINGCHAPTER 66. IMAGING DIAGNOSIS OF CIRRHOSIS AND CHRONIC HAPATITISDr. K. Ito, Yamaguchi University, Department of Radiology, School of Medicine, Yamaguchi, JapanCHAPTER 67. DIFFERENTIATION OF HEPATIC TUMORS: COLOR DOPLER IMAGINGCHAPTER 68. METASTASIS OF HEPATOCELLULAR CARCINOMA TO THE HEART: MAGNETIC RESONANCE IMAGINGCHAPTER 69. LIVER METASTASES FROM COLORECTAL CANCER: ULTRASOUND IMAGING OF FLOW PATTERNS CHAPTER 70. HEPATIC COLORECTAL METASTASES DETECTION BEFORE RESECTONING: 18F-FLUORODEOXYGLUCOSE- POSITRON EMISSION TOMOGRAPHY SCANNINGCHAPTER 71. CONTRAST-ENHANCEDSONOGRAPHYFOR HEP ATOCELLULAR CARCINOMA PROSTATE CANCER CHAPTER 72. FAST ACQUISITION-WEIGHTED THREE-DIMENSIONAL PROTON MAGNETIC RESONANCE SPECTROSCOPY IMAGINGCHAPTER 73. CHRONIC PROSTATITIS: THREE DIMENSIONAL PROTON MAGNETIC RESONANCE SPECTROSCOPIC IMAGINGCHAPTER 74. RECURRENT PROSTATE CANCER: MAGNETIC RESONANCE IMAGING OR COMPUTED TOMOGRAPHY IN PATIENTSCHAPTER 75. PROTON MAGENTIC RESONANCE SPECTROSCOPIC IMAGING CHAPTER 76. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHYCERVICAL CANCER CHAPTER 77. CERVICAL INTRAEPITHELIAL NEOPLASIA: DOUBLE RATIO FLUORESCENCE IMAGINGCHAPTER 78. RECURRENT CERVICAL CANCER: 18F_ FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHYCHAPTER 79. UTERINE CERVICAL CARCINOMA: PREOPERATIVE MAGNETIC RESONANCE IMAGING STAGINGBRAIN CANCER CHAPTER 80. NEUROBLASTOMA: COMPUTED TOMOGRAPHYCHPATER 81. NEUROENDOCRINE TUMORS: 618p-FLUORODOPA-POSITRON EMISSION TOMOGRAPHYCHAPTER 82. BRAIN TUMORS: IMAGING OF IRON OXIDE WITH MAGNETIC RESONANCE IMAGINGCHAPTER 83. 18F-FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHYCHAPTER 84. COMPARISON OF 18F-FLUORODEOXYGLUCOSE AND "C-METHIONINE FOR POSITRON EMISSION - GUIDED STEREOTACTIC IMAGINGCHAPTER 85. GLIOMA: TEMOZOLOMIDE TREATMENT AND MAGNETIC RESONANCE IMAGINGHanna O. Maenpaa, Department of Oncology, Helsinki University Central Hospital, FinlandCHAPTER 86. DIFFUSION TENSOR IMAGING OF BRAIN TUMORSCHAPTER 87. IMAGING ENDOGENOUS GENE EXPRESSION IN BRAIN CANCERGASTROINTESTINAL CANCERCHAPTER 88. RESISTANCE TO IMATINIB THERAPY IN A METASTATIC GASTROINTESTINAL STROMAL TUMOR: COMPUTED TOMOGRAPHYCHAPTER 89. IMAGING OF GASTROINTESTINAL STROMAL TUMORSCHAPTER 90. ANTIANGIOGENIC THERAPY FOR GASTROINTESTINAL TUMORSCHAPTER 91. TREATMENT OF INTESTINAL TUMORS WITH AGMATINECHAPTER 92. TREATMENT OF GASTROINTESTINAL CANCER WITH CAPECIT ABINETMITOMYCIN CCHAPTER 93. ADJUVANT ORAL TAGAFUR TREATMENT FOR GASTRIC CANCER PATIENTS CHAPTER 94. TREATMENT OF INOPERABLE GASTRIC CANCER: COMPARISON BETWEEN MITOMYCIN-CISPLA TIN - DOXIFLURIDINE AND CISPLATIN-DOXIFLURIDINECHAPTER 95. CLINICAL RESPONSE OF METASTATIC GASTRIC CANCER TO 5-DEOXY-5-FLUOROURIDINE?CHAPTER 96. CHEMOSENSITIVITY OF GASTRIC CANCER TO 5-FLUOROURACILCHAPTER 97. IN VIVO DETECTION BY ELECTRON PARAMAGNETIC RESONANCE IMAGINGCHAPTER 98. GASTROINTESTINAL STROMAL TUMORS OF THE STOMACH: COMPUTED TOMOGRAPHY CHAPTER 99. GASTRIC MOTILITY DISORDERS: REAL TIME MAGNETIC RESONANCE IMAGINGCHAPTER 100. HAND-ASSISTED LAPROSCOPIC SURGERY FOR ADVANCED-STAGE PROXIMAL GASTRIC CANCERCHAPTER 101. EARLY GASTRIC CANCER: NARROW BAND IMAGINGCHAPTER 102. EARLY GASTRIC CANCER: MAGNIFYING ENDOSCOPYOVARIAN CANCERCHAPTER 103. ADVANCED OVARIAN CARCINOMA: COMPUTED TOMOGRAPHYCHAPTER 104. PREDICTING SUBOPTIMAL CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN CARCINOMA: COMPUTED TOMOGRAPHY SCANNINGCHAPTER 105. TREATMENT OF OVARIAN CANCER WITH CARBOPLATIN FOLLOWED BY PACLIT AXEL AND GEMCIT ABINCHAPTER 106. SYNERGIC EFFECT OF SU5416 AND CISPLATIN IN CYTOTOXICITY IN OVARIAN TUMOR CELLSCHAPTER 107. OVARIAN CHORIOCARCINOMA: COMPUTED TOMOGRAPHY, MAGNETIC RESONANCE IMAGING AND SONOGRAPHYCHAPTER 108. COLOR DOPPLER ULTRASOUND EXAMINATIONCOLORECTAL CANCERCHAPTER 109. COLON CANCER: 18F-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHYCHAPTER 110. EARLY COLON CANCER DETECTOIN: 18F_ FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHYCHAPTER 111. COMPUTED TOMOGRAPHIC COLONOGRAPHY WITH COMPUTER - AIDED DETECTIONCHAPTER 112. FUNCTIONAL IMAGING OF COLORECTAL AND ESOPHAGEAL CANCER: POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHYCHAPTER 113. METASTATIC COLORECTAL CANCER: 18F_ FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHYCHAPTER 114. COMPUTED TOMOGRAPHIC COLONOGRAPHY CHAPTER 115. LAXATIVE-FREE COLONOGRAPHY: COMPUTED TOMOGRAPHYGALLBLADDER CANCER CHAPTER 116. 18F-FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHYESOPHAGEAL CANCER CHAPTER 117. POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY FUNCTIONAL IMAGINGHEAD AND NECK CANCER CHAPTER 118. HEAD AND NECK SQUAMOUS CELL CARCINOMA: IMAGING WITH RADIATION DOSIMETRY OF 99m Tc-LABELED C 225BRONCHIAL CANCERCHAPTER 119. AUTOFLUORESCENCE SPECTROSCOPY-DIFFUSE REFLECTANCE SPECTROSCOPYBONE CANCER CHAPTER 120. BONE AND SOFT TISSUE TUMORS: IN VIVO IH MAGNETIC RESONANCE SPECTROSCOPY METASTATIC MEDULLARY THYROID CANCER CHAPTER 121. IlI In - DTP A - octreotide and 131 I/123I - MIBGCHAPTER 122. THYROID NEOPLASMS: THREE - DIMENSIONAL RECONSTRUCTION OF ANGIOARCHITECTURECHAPTER 123. ANAPLASTIC THYROID CANCER: MULTIMODALITY IMAGING PANCREATIC DUCTAL ADENOCANCER: CHAPTER 124. ULTRASONOGRAPHYLYMPHOMA CHAPTER 125. LYMPHOMA: POSITRON EMISSION TOMOGRAPHYCHAPTER 126. NON-HODGKIN'S LYMPHOMA: COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING MELANOMA LESIONS CHAPTER 127. MELANOMA LESSIONS: 99m Tc - INTERLEUKIN - 2 SCINTIGRAPHYMULTIPLE MYELOMA CHAPTER 128. COMPUTED TOMOGRAPHY
“Professor Hayat has assembled a distinguished group of scientists and clinicians from around the world and has provided a very timely discussion of functional imaging for the diagnosis and treatment of solid organ cancers. Dr. Hayat’s introduction and discussion of imaging techniques are comprehensive. He has clearly outlined the roles of functional imaging in defining the nature of primary organ cancers and their metastases. --Akhouri A. Sinha, Professor of Genetics, Cell Biology, and Development, University of Minnesota; Senior Research Scientists, Veterans Affairs Medical Center, Minneapolis, MN